Save time¹. Ensure exam completeness². Deliver expert-level screening¹.
BrightHeart’s B-Right AI Platform empowers clinicians and sonographers - facilitating comprehensive and standardized expert-level assessments during routine anatomy scans.
Prenatal ultrasound assessments are variable and complex, resulting in inconsistent documentation, inefficient workflows, and missed congenital heart defects (CHDs).
The B-Right AI Platform enables expert level care, supporting exam completeness and confident interpretation.
Expert-Level Screening of Complex Anatomy
Detection of major CHDs²
Reduction in false-negative errors¹
Reduction in false-positive errors¹
Optimized Workflow Across the Full Scan
Reduction in incomplete fetal heart scans¹⁰
Confidence improvement¹
Faster reading times¹
Seamless integration
BrightHeart's standalone AI platform integrates seamlessly into any existing workflow as a plug and play solution that’s 100% compatible with your existing setup. No disruption, no complexity - just quiet, powerful support that works within existing ultrasound workflows, from first view to final review.
✔ Compatible with major ultrasound manufacturers and existing reporting solutions
✔ Automatic display on cart-side tablet during scan
✔ Results summarized and linked in reporting software
✔ Detailed assessments on standalone web platform
BrightHeart AI Demo: DICOM file with expert-level AI annotation of key views and findings
Automatic image and cine clip analysis and processing using AI algorithms
Live AI assessment of full exam completeness during the ultrasound capture
Detailed AI evaluation of fetal heart structures, highlighting abnormal findings or confirming their absence
Publication Highlights
AI sensitivity for detecting severe CHD indicators¹¹
AI specificity in confirming normality¹¹
BrightHeart in the News
Congenital heart defects are the most common birth defects worldwide.
Every minute, 2 children around the world are born with a congenital heart defect (5)
Yet nearly 50% of fetal cardiac scans are incomplete (6)
With challenges spanning acquisition and interpretation, up to 70% of congenital heart defects go undetected during pregnancy (7, 8, 9)
At BrightHeart, our mission is to deliver expert level ultrasound care worldwide - regardless of resources, settings, or expertise.
Lam-Rachlin et. al., “Use of Artificial Intelligence–Based Software to Aid in the Identification of Ultrasound Findings Associated With Fetal Congenital Heart Defects,” Obstetrics & Gynecology, 2025.
Rebarber et. al., “Optimizing screening for severe congenital heart defects on prenatal ultrasound using eight suspicious findings and artificial intelligence”, ISUOG abstract, 2025.
B-Right Views is an FDA-cleared Class II medical device, please refer to product regulatory information for more details.
B-Right Screen is an FDA-cleared Class II medical device, please refer to product regulatory information for more details.
https://childrensheartlink.org/congenital-heart-disease-facts/#:~:text=Every%205%20minutes%2C%2010%20children,1.3%20million%20children%20each%20year.
https://pmc.ncbi.nlm.nih.gov/articles/PMC7317409/
https://pubmed.ncbi.nlm.nih.gov/12084585/
https://pubmed.ncbi.nlm.nih.gov/18657826/
https://pubmed.ncbi.nlm.nih.gov/32795094/
Lam-Rachlin et. al., “Enhancing Ultrasound Standard View Completion in Fetal Heart Screening with an AI Software,” ISUOG abstract, 2025.
Zelop et al., “Artificial Intelligence Accurately Detects Fetal Ultrasound Findings Suspicious For Major Congenital Heart Defects,” Obstetrics & Gynecology, 2025. *Stats presented among conclusive cases.
Note: Images shown may represent the range of products and differ from versions, or be for illustration purposes only, and may not be an exact representation of the product.
For use only in countries with applicable health authority registrations: please contact us for more information.